SRSF3 Alleviates Ischemic Cerebral Infarction Damage by Activating the PI3K/AKT Pathway
Developmental Neuroscience · 2023
DOI: 10.1159/000535690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Neuroscience, 2023. Verfasst von Liangliang Cui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China. Hauptthemen laut MEDLINE: Apoptosis, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Serine-Arginine Splicing Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ischemic cerebral infarction is one of cerebrovascular diseases with high incidence, disability rate, and mortality globally, and neuronal cell apoptosis is a crucial cause of brain injury during cerebral infarction.
Methods
A middle cerebral artery occlusion (MCAO) model was built in Sprague-Dawley rats to simulate ischemic cerebral infarction. An in vitro model of ischemic cerebral infarction was constructed in BV2 cells with the treatment of oxygen-glucose deprivation (OGD). The role and mechanism of serine/arginine-rich splicing factor 3 (SRSF3) in ischemic cerebral infarction were investigated both in animal and cell models.
Results
The expression of SRSF3 was downregulated in MCAO-treated rats. Overexpression of SRSF3 reduced the neurological scores, brain water content, and infarct volume in MCAO-induced rats. Increased apoptosis in neurons accompanied with the abnormal expressions of apoptosis-related proteins in MCAO-induced rats were revised with the upregulation of SRSF3. Also, a diminished cell viability and elevated apoptosis rate were indicated in OGD-induced BV2 cells, which were reversed with the overexpression of SRSF3. Besides, OGD induced an enhancement in the relative protein expression of programmed cell death protein 4 (PDCD4) and a reduction in the relative expression of p-PI3K/PI3K and p-AKT/AKT, which were inverted with the upregulation of SRSF3 in BV2 cells. Overexpression of PDCD4 abolished the role of SRSF3 in cell viability, apoptosis rate, and the level of the PI3K/AKT pathway in OGD-induced BV2 cells.
Conclusion
SRSF3 improved ischemic cerebral infarction via PDCD4 in vivo and in vitro, which was closely associated with the PI3K/AKT signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Zitieren
APA
Cui, L., Zhao, S., & Liu, H. (2023). SRSF3 Alleviates Ischemic Cerebral Infarction Damage by Activating the PI3K/AKT Pathway. Developmental Neuroscience. https://doi.org/10.1159/000535690
Vancouver
Cui L, Zhao S, Liu H. SRSF3 Alleviates Ischemic Cerebral Infarction Damage by Activating the PI3K/AKT Pathway. Developmental Neuroscience. 2023. doi:10.1159/000535690
BibTeX
@article{Cui2023,
author = {Cui, Liangliang and Zhao, Shuying and Liu, Hong},
title = {SRSF3 Alleviates Ischemic Cerebral Infarction Damage by Activating the PI3K/AKT Pathway},
journal = {Developmental Neuroscience},
year = {2023},
doi = {10.1159/000535690}
}
EUVIMED